What is fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Fibrosis?

Fibrosis is the abnormal accumulation of collagen and other extracellular matrix components in tissue, representing excessive scar formation that can lead to organ dysfunction and failure. 1

Core Definition and Pathophysiology

Fibrosis represents a pathological deviation from normal wound healing, characterized by:

  • Excessive deposition of structural and matricellular proteins in the extracellular space 2
  • Transformation of resting fibroblasts into myofibroblasts that produce excessive extracellular matrix 3
  • A process that can affect virtually any organ system including heart, lung, liver, kidney, skin, and bone marrow 3, 4

The condition is always a sequela of inflammatory processes, regardless of the underlying cause 5. Multiple etiologies channel into the same stereotypical pathways, including acute and chronic ischemia, hypertension, chronic viral infection, environmental exposures, and genetic diseases 3.

Types of Fibrosis

Fibrosis can be classified based on cellular activity:

  • Active fibrosis: Abnormal collagen accumulation with increased stromal cells (fibroblasts or myofibroblasts) 1
  • Inactive fibrosis: Abnormal collagen accumulation without increased stromal cell numbers 1

Clinical Significance

Fibrosis is responsible for up to 45% of all deaths in the industrialized world 6, making it a major contributor to global morbidity and mortality 3. The amount of fibrosis correlates directly with:

  • Risk of developing cirrhosis in chronic liver disease 7
  • Development of organ-specific complications 7
  • Overall prognosis across different organ systems 7

Key Pathogenic Mechanisms

The fibrotic process involves a complex network of cellular interactions:

  • Immune cells (predominantly monocytes/macrophages) play central roles 3
  • Endothelial cells and parenchymal cells contribute to profibrotic cellular crosstalk 3
  • Leading mediators include transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), interleukins (IL-10, IL-13, IL-17), and danger-associated molecular patterns 3, 4

Important Clinical Considerations

Fibrosis was historically thought to be irreversible, but both preclinical models and clinical trials have demonstrated it is a highly dynamic process 6. This plasticity has clear implications for therapeutic interventions, though effective antifibrotic therapies remain limited 2, 4.

The condition differs from desmoplasia, which specifically refers to the cellular fibroinflammatory response accompanying invasive carcinoma and should not be used in the absence of invasive cancer 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.